Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FGFR1 | P11362 | 9/20 | 0.50 |
| ▸ | SRC | P12931 | 3/20 | 0.50 |
| ▸ | HTT | P42858 | 2/20 | 0.45 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.44 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.43 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.43 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17940725 | 0.84 | FGFR1 (0.59) | FGFR1SRCHTTALDH1A1HPGD | |
| SCHEMBL24844368 | 0.75 | FGFR1 (0.40) | FGFR1SRCHTTALDH1A1 | |
| SCHEMBL23846263 | 0.74 | FGFR1 (0.76) | FGFR1SRCHTTALDH1A1HPGD | |
| SCHEMBL19848423 | 0.73 | HTT (0.59) | FGFR1SRCHTTALDH1A1HPGD | |
| SCHEMBL19915930 | 0.73 | FGFR1 (0.62) | FGFR1SRCHTTALDH1A1 | |
| SCHEMBL8009170 | 0.72 | FGFR1 (0.60) | FGFR1SRCHTTALDH1A1 | |
| SCHEMBL17940687 | 0.72 | HTT (0.57) | FGFR1SRCHTTALDH1A1HPGD | |
| SCHEMBL1761803 | 0.71 | GABRA1 (0.78) | FGFR1ALDH1A1HPGD | |
| SCHEMBL11678470 | 0.70 | FGFR1 (0.65) | FGFR1SRCHTTALDH1A1HPGD | |
| SCHEMBL17940768 | 0.70 | HPGD (0.53) | FGFR1ALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230006152-A1 | METAL COMPLEX AND LIGHT EMITTING DEVICE | CITY UNIVERSITY OF HONG KONG (HK) | 2023-01-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230006152-A1 | METAL COMPLEX AND LIGHT EMITTING DEVICE | OCIAD1, OCIAD2, OPRD1 | FGFR1 4472/4885SRC 3518/4885HTT 2976/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.